麦肯锡：医疗科技脉搏 ( 英文 84页)

---

医疗技术领导者正在制定战略，以在不确定的宏观经济和不断变化的行业趋势中抓住下一波价值创造浪潮

Contents

Introduction: Medtech’s value-creation imperative

Patients in need and uncertain shareholders have medtech leaders plotting their strategies for a new wave of value creation.

Reimagining R&D to drive sustainable growth

To unlock sustainable long-term growth, medtech companies should aim for significant improvements to R&D and product development.

Cracking the code of software innovation

Software development calls for an entirely different approach from traditional product development methods.

Medtech companies can borrow a page from leading software firms.

Bringing hardware and software together into digital health ecosystems

Medtech companies can expand their role in digital healthcare ecosystems by combining devices and data to improve care outcomes.

Building a next-generation medtech commercial model 

Commercial models must evolve to support new types of offerings, adapt to changing customer expectations, and position companies to succeed in the decade ahead.

Reimagining operations for the challenges of the next decade

As medtech companies emerge from the COVID-19 pandemic, leaders are scrutinizing operations to find ways to better serve patients and bolster competitiveness.

Committing to ESG as a differentiator

An environmental, social, and governance (ESG) strategy is not merely a compliance checklist item; it is an untapped opportunity for medtech companies to differentiate their devices.

Updating the post-COVID-19 playbook for M&A

M&A could help the medtech industry boost value creation, but only if companies can adapt their dealmaking approaches to changing macroeconomic conditions.

Competing in China: Medtech multinational companies’ way forward

China will continue to be a critical market for medtech multinational companies despite market uncertainties.

Big moves are in order.

目录

引言：医疗技术产生价值的迫切需求

有需求的患者和不确定的股东让医疗技术领导者谋划他们的战略，以迎接新一波的价值创造。

重新构想研发以推动可持续增长

为了实现可持续的长期增长，医疗技术公司应致力于显著改进研发和产品开发。

破解软件创新之谜

软件开发需要与传统产品开发方法完全不同的方法。

医疗技术公司可以借鉴领先的软件公司的经验。

将硬件和软件融合到数字健康生态系统中

医疗技术公司可以通过将设备和数据结合起来以改善护理结果，扩大其在数字医疗生态系统中的作用。

构建下一代医疗技术商业模式

商业模式必须发展，以支持新类型的产品，适应不断变化的客户期望，并使公司能够在未来十年取得成功。

重新构想未来十年的挑战的运营方式

随着医疗技术公司从COVID-19大流行中走出来，领导者正在审视运营，寻找更好地为患者服务并增强竞争力的方法。

承诺ESG作为差异化策略

环境、社会和治理（ESG）战略不仅仅是一份合规检查清单项目；它是医疗技术公司区分其设备的未开发机会。

更新COVID-19后的并购策略手册

并购可能有助于医疗技术行业增加价值创造，但只有公司能够调整其交易方法以适应不断变化的宏观经济条件。

在中国竞争：医疗技术跨国公司的前进之路

尽管市场不确定性，中国仍将是医疗技术跨国公司的关键市场。

需要采取重大举措。